Scientists have developed CCI-38, a compound that targets YTHDF2 to improve CAR T cell therapy and overcome immune evasion in cancer.

Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their effectiveness has plateaued due to...

Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug venetoclax works synergistically with CAR T-cell immunotherapy...

Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same...

A basic dietary supplement in a ketogenic diet can enhance the function of 'CAR T' cells - a personalized treatment that reprograms patients' immune...

THURSDAY, Dec. 12, 2024 -- It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective new...

The COVID-19 pandemic and recent Nobel Prize recognition have spotlighted mRNA therapies as a promising approach for diseases like cancer. Found in...

Researchers are shining a light on cancer cells' energy centers – literally – to damage these power sources and trigger widespread cancer cell...

A recently published study led by Wayne State University, USA, on a new approach to understanding chronic inflammation could lead to new advancements...

MIT researchers have developed a groundbreaking imaging method that can penetrate twice as deep into living tissue as previous techniques. This new...